Clinical Trial Update: Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic Dermatitis [NA]

View source ↗

Summary

This clinical-trial update reports on the therapeutic efficacy of a topical postbiotic, N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA), in pediatric patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) (N-(1-carbamoyl-2-phenyl-ethyl) Butyramide)

Snippet

Sponsor: Federico II University | Conditions: Atopic Dermatitis | NA | Status: COMPLETED